Commercializing Flow Chemistry Summit on October 16-18, 2023 in Boston, United States

The 4th Annual Commercializing Flow Chemistry Summit is dedicated to empowering you with the tools and knowledge to revolutionize your process efficiency and leverage emerging technologies through strategic flow chemistry.

With the increasing demand for superior flow technology, our summit focuses on transforming your approach to process efficiency, expanding your emerging technology toolbox, and achieving substantial economic gains through strategic flow chemistry.

Immerse yourself in unparalleled content and valuable takeaways that will help you streamline your continuous chemistry research, leading it towards scaled commercial applications. But that's not all - the benefits don't stop there! Engage in interactive workshops that will sharpen your skills, and seize the multitude of networking opportunities that await you.

This highly-anticipated meeting will unite 80+ process chemists, engineering experts, and modellers for a masterclass in adding tangible value to your early to late-stage process development. This is an unmissable opportunity to connect with industry peers, gain insights from leading professionals including Novartis, Boehringer Ingelheim Sanofi, AbbVie, Eli Lily and many more, to stay ahead in the rapidly evolving field of flow chemistry.

Join us in Boston this October and unlock the true potential of your research and business endeavours. Together, we'll shape the future of flow chemistry and drive innovation like never before!

URLs:
Brochure: https://go.evvnt.com/1854267-0?pid=10008
Tickets: https://go.evvnt.com/1854267-1?pid=10008
Sponsor: https://go.evvnt.com/1854267-4?pid=10008

Time: 9:00 AM - 6:00 PM

Prices:

Drug Developer, API and Fine Chemicals | Conference Only: USD 1300.00,

Flow Chemistry Solution Provider | Conference Only: USD 1400.00

Speakers: Ananda Herath, Principal Scientist at Novartis, Andrew Brusoe, Senior Scientist at Boehringer Inhelheim , Grace Ahlqvist, Process Chemist at Sanofi, Kaid Harper, Principal Scientist at AbbVie, Nick Kaczorowski, Chemical Engineer at Eli Lilly, Sean Kelly, Scientist III at Genentech , Thomas Toupy, Postdoctoral Associate and Scientist at Takeda, Yasser Jangjou, Senior Scientist - Process Modeller at Sanofi